Masataka Nonaka
President at Tauns Laboratories, Inc.
Net worth: 76 M $ as of 2024-05-30
Profile
Masataka Nonaka is currently the Representative Director at TAUNS Holdings Co., Ltd.
and the President & Representative Director at TAUNS Laboratories, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Tauns Laboratories, Inc.
 Tauns Laboratories, Inc. Medical SpecialtiesHealth Technology TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan. 28.95% | 2024-06-19 | 28,947,600 ( 28.95% ) | 76 M $ | 2024-05-30 |
Masataka Nonaka active positions
| Companies | Position | Start |
|---|---|---|
TAUNS Holdings Co., Ltd.
 TAUNS Holdings Co., Ltd. Financial ConglomeratesFinance TAUNS Holdings Co., Ltd. engages in the management and operation of its group of companies that conduct research and development, manufacturing, and sales of in-vitro diagnostic drugs. The company was founded on April 14, 2016 and is headquartered in Izunokuni, Japan. | Director/Board Member | - |
Tauns Laboratories, Inc.
Tauns Laboratories, Inc. Medical SpecialtiesHealth Technology TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan. | President | 2017-08-31 |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
 | Health Technology |
| Private companies | 1 |
|---|---|
TAUNS Holdings Co., Ltd.
TAUNS Holdings Co., Ltd. Financial ConglomeratesFinance TAUNS Holdings Co., Ltd. engages in the management and operation of its group of companies that conduct research and development, manufacturing, and sales of in-vitro diagnostic drugs. The company was founded on April 14, 2016 and is headquartered in Izunokuni, Japan. | Finance |
- Stock Market
- Insiders
- Masataka Nonaka
